Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Window of Opportunity Trial Evaluating the Oral TGF-beta Receptor I Inhibitor Vactosertib in Patients Undergoing Standard of Care Chemoradiotherapy for Locally Advanced Esophageal Adenocarcinoma

NCT06044311 is registered in ClinicalTrials.gov with Melissa Lumish as lead sponsor.

NCT NCT06044311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06044311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Window of Opportunity Trial Evaluating the Oral TGF-beta Receptor I Inhibitor Vactosertib in Patients Undergoing Standard of Care Chemoradiotherapy for Locally Advanced Esophageal Adenocarcinoma
Lead sponsor
Melissa Lumish
Phase
Phase 2
Overall status
Recruiting
Start date
September 30, 2024
Completion date
September 30, 2027
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma esophagus, locally advanced adenocarcinoma, siewert type i adenocarcinoma of esophagogastric junction, siewert type ii adenocarcinoma of esophagogastric junction